Literature DB >> 25814490

A roadmap for discovery and translation in lymphoma.

David M Weinstock1, Riccardo Dalla-Favera2, Randy D Gascoyne3, John P Leonard4, Ronald Levy5, Izidore S Lossos6, Ari M Melnick4, Grzegorz S Nowakowski7, Oliver W Press8, Kerry J Savage9, Margaret A Shipp1, Louis M Staudt10.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25814490      PMCID： PMC4375113          DOI： 10.1182/blood-2015-01-623777

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D.

Authors:  H F OETTGEN; P CLIFFORD; D BURKITT
Journal:  Cancer Chemother Rep       Date:  1963-04

2.  T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.

Authors:  Michael Kalos; Bruce L Levine; David L Porter; Sharyn Katz; Stephan A Grupp; Adam Bagg; Carl H June
Journal:  Sci Transl Med       Date:  2011-08-10       Impact factor: 17.956

3.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

4.  Cure of gastric lymphoma with antibiotics.

Authors:  P Pescatore; M Heine; B C Manegold
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

Review 5.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

Authors:  Stephen M Ansell; Alexander M Lesokhin; Ivan Borrello; Ahmad Halwani; Emma C Scott; Martin Gutierrez; Stephen J Schuster; Michael M Millenson; Deepika Cattry; Gordon J Freeman; Scott J Rodig; Bjoern Chapuy; Azra H Ligon; Lili Zhu; Joseph F Grosso; Su Young Kim; John M Timmerman; Margaret A Shipp; Philippe Armand
Journal:  N Engl J Med       Date:  2014-12-06       Impact factor: 91.245

7.  Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Authors:  Catherine M Bollard; Stephen Gottschalk; Vicky Torrano; Oumar Diouf; Stephanie Ku; Yasmin Hazrat; George Carrum; Carlos Ramos; Luis Fayad; Elizabeth J Shpall; Barbara Pro; Hao Liu; Meng-Fen Wu; Daniel Lee; Andrea M Sheehan; Youli Zu; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  J Clin Oncol       Date:  2013-12-16       Impact factor: 44.544

8.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Authors:  C M Rooney; C A Smith; C Y Ng; S Loftin; C Li; R A Krance; M K Brenner; H E Heslop
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321
  8 in total
  9 in total

Review 1.  CAR-T Cell Therapy for Lymphoma.

Authors:  Carlos A Ramos; Helen E Heslop; Malcolm K Brenner
Journal:  Annu Rev Med       Date:  2015-08-26       Impact factor: 13.739

2.  Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.

Authors:  Xiaoyu Jiang; Xiaoqing Lu; Yu Zhang; Leda Lacaria; Brett J Schuchardt; David C Mikles; Marco Magistri; Idoia García-Ramírez; Isidro Sanchez-Garcia; Amjad Farooq; Ramiro E Verdun; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2019-08-13

3.  Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis.

Authors:  Shengbing Zang; Jia Li; Haiyan Yang; Hongxiang Zeng; Wei Han; Jixiang Zhang; Minjung Lee; Margie Moczygemba; Sevinj Isgandarova; Yaling Yang; Yubin Zhou; Anjana Rao; M James You; Deqiang Sun; Yun Huang
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

Review 4.  The Microscope as a Tool for Disease Discovery-A Personal Voyage.

Authors:  Elaine S Jaffe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

5.  Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.

Authors:  Olivia Marini; Cecilia Spina; Elda Mimiola; Adriana Cassaro; Giovanni Malerba; Giuseppe Todeschini; Omar Perbellini; Maria Scupoli; Giuseppe Carli; Davide Facchinelli; Marco Cassatella; Patrizia Scapini; Cristina Tecchio
Journal:  Oncotarget       Date:  2016-05-10

6.  Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy.

Authors:  Hongfeng Yuan; Meilan He; Fan Cheng; Rosemary Bai; Suzane Ramos da Silva; Ricardo C T Aguiar; Shou-Jiang Gao
Journal:  Oncotarget       Date:  2017-02-28

Review 7.  The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.

Authors:  Hans G Drexler; Hilmar Quentmeier
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 8.  Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Authors:  Benedetta Apollonio; Nikolaos Ioannou; Despoina Papazoglou; Alan G Ramsay
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

9.  A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.

Authors:  Long Wang; Kenneth N Holder; Avvaru N Suhasini; An-Ping Lin; Harshita Bhatnagar; Sang-Woo Kim; August W Moritz; Ricardo C T Aguiar
Journal:  Leukemia       Date:  2015-10-27       Impact factor: 11.528
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.